Search

Search Results
Results 261 - 270 of 271 for Scleroderma
  • Coversyl
    Drug - 8 Feb 2024
    Consumer Medicine Information (CMI) about Coversyl intended for persons living in Australia.
  • Flolan for Injection
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Flolan for Injection intended for persons living in Australia.
  • Zan-Extra
    Drug - 24 Feb 2023
    Consumer Medicine Information (CMI) about Zan-Extra intended for persons living in Australia.
  • Perisyl Combi
    Drug - 6 Jan 2023
    Consumer Medicine Information (CMI) about Perisyl Combi (perindopril erbumine and indapamide hemihydrate) intended for persons living in Australia.
  • Reaptan
    Drug - 2 Aug 2022
    Consumer Medicine Information (CMI) about Reaptan (Perindopril/amlodipine [pronounced per-in-do-pril/ am-load-i-peen]) intended for persons living in Australia.
  • Accuretic
    Drug - 27 Jul 2022
    Consumer Medicine Information (CMI) about Accuretic intended for persons living in Australia.
  • Prexum Combi
    Drug - 20 Jul 2022
    Consumer Medicine Information (CMI) about Prexum Combi (perindopril and indapamide) intended for persons living in Australia.
  • Coversyl Plus
    Drug - 20 Jul 2022
    Consumer Medicine Information (CMI) about Coversyl Plus (perindopril and indapamide) intended for persons living in Australia.
  • Prexum
    Drug - 15 Jul 2022
    Consumer Medicine Information (CMI) about Prexum (perindopril) intended for persons living in Australia.
  • Perindo
    Drug - 6 Jul 2022
    Consumer Medicine Information (CMI) about Perindo (perindopril) intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback